Translational Research and Experimental Therapeutics
The objectives of our Research Program are to integrate clinical and laboratory research efforts to improve the management of patients with urologic cancers. The primary objective is to develop, advance, and subsequently offer state-of-the-art treatments to patients with urologic cancers by developing improved therapies and treatment paradigms that incorporate novel anti-cancer agents and technologies as a compliment to conventional surgical therapy. In translational research, discoveries from the laboratory are applied directly to patient care while observations from the clinic are explored at the laboratory bench.
The Translational Research Program is founded on the following philosophical triumvirate: